Maura Sien

Maura Sien

Auto-generated profile, based on publicly available information

Maura Sien

Children’s Mercy Research Institute

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2022 in Archives of Disease in Childhood - Fetal and Neonatal Edition
Verified
Journal Article
Open access
PDF file
MSMaura E Sien
Maura E Sien
ARAmie L Robinson
Amie L Robinson
HHHouchun H Hu
Houchun H Hu
CNChris R Nitkin
Chris R Nitkin
AHAra S Hall
Ara S Hall
SCSherwin Chan
Sherwin Chan
Objective A portable, low-field MRI system is now Food and Drug Administration cleared and has been shown to be safe and useful in adult intensive care unit settings. No neonatal studies have been performed. The objective is to assess our preliminary experience and assess feasibility of using the portable MRI system at the bedside in a neonatal intensive care unit (NICU) at a quaternary children’s hospital. Study design This was a single-site prospective cohort study in neonates ≥2 kg conducted between October and December 2020. All parents provided informed consent. Neonates underwent portable MRI examination in the NICU with support equipment powered on and attached to the neonate during the examination. A paediatric radiologist interpreted each portable MRI examination. The study outcome variable was percentage of portable MRI examinations completed without artefacts that would hinder diagnosis. Findings were compared between portable MRI examinations and standard of care examinations. Results Eighteen portable, low-field MRI examinations were performed on 14 neonates with an average age of 29.7 days (range 1–122 days). 94% (17 of 18) of portable MRI examinations were acquired without significant artefact. Significant intracranial pathology was visible on portable MRI, but subtle abnormalities were missed. The examination reads were concordant in 59% (10 of 17) of cases and significant pathology was missed in 12% (2 of 17) of cases. Conclusion This single-centre series demonstrated portable MRI examinations can be performed safely with standard patient support equipment present in the NICU. These findings demonstrate that portable MRI could be used in the future to guide care in the NICU setting. Trial registration number NCT04629469.

18 November 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
JWJessica S. Wallisch
Jessica S. Wallisch
AWAsdis Finnsdottir Wagner
Asdis Finnsdottir Wagner
JDJohn M. Daniel
John M. Daniel
ATAllison Taber
Allison Taber
MSMaura Sien
Maura Sien
SCSherwin Chan
Sherwin Chan
Background: Despite improving outcomes, extracorporeal membrane oxygenation (ECMO) remains associated with high rates of acute brain injury, impacting survival and outcomes. Clinical imaging modalities, including computed tomography and standard‐field magnetic resonance imaging (≥1.5 Tesla), have either limited early detection of ischemic‐type injuries or are incompatible with ECMO, causing diagnostic delays. A Food and Drug Administration–cleared ultra‐low‐field portable magnetic resonance imaging (pMRI; 0.064 Tesla) has shown promise in acute brain injury detection and use with MRI‐unsafe equipment, but pediatric ECMO data are limited. Methods: This institutional review board–approved, single‐center study was conducted at a quaternary children’s hospital. Neonatal and pediatric patients on ECMO from September 2023 to August 2024 were screened. Enrolled subjects underwent pMRI using Swoop (Hyperfine, Guilford, CT). Feasibility (resource use, concurrent equipment) and safety metrics (ECMO flow/vitals, cannula displacement) were collected along with patient/ECMO variables and all head imaging. Two blinded pediatric neuroradiologists independently reviewed images. Results: Of 41 screened patients, 20 were enrolled, 16 had pMRI attempted, and 11 completed full imaging (T1, T2, fluid‐attenuated inversion recovery, and diffusion‐weighted imaging). Median staff required for pMRI was 6 (interquartile range, 5–7) versus 7 (interquartile range, 7–7) for head computed tomography. Median pMRI positioning and imaging time was 66 (interquartile range, 61–70) minutes versus 75 (interquartile range, 70–79) minutes for head computed tomography with intrahospital transport. One subject had a ≥20% but clinically nonsignificant decrease in blood pressure; no safety events were attributable to pMRI. A total of 70% to 75% of image sets were of diagnostic quality. Conclusions: pMRI is feasible in pediatric ECMO with no clinically relevant complications, lower resource use, and generation of diagnostic quality images in our cohort. Registration Information: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT06074406.

13 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
JWJessica S Wallisch
Jessica S Wallisch
AWAsdis Finnsdottir Wagner
Asdis Finnsdottir Wagner
JDJohn M Daniel
John M Daniel
ATAllison Taber
Allison Taber
MSMaura Sien
Maura Sien
SCSherwin Chan
Sherwin Chan
Introduction Extracorporeal membrane oxygenation (ECMO) outcomes continue to improve, yet high rates of acute brain injury (ABI) threaten survival with significant morbidity for ECMO survivors. Currently available imaging modalities [ultrasound and computed tomography (CT)] have low early detection rates for hypoxic-ischemic and cerebrovascular injuries, delaying the diagnosis of ABI while on ECMO. CT sensitivity increases only when it may be too late to effectively intervene. High-field (>1.5 Tesla) magnetic resonance imaging (MRI), the gold standard to diagnose ischemic brain injury, is not compatible with ECMO. An FDA-cleared ultralow-field (0.064 Tesla) portable MRI (pMRI) has been studied in diverse types of ABI and with equipment that is typically not MRI compatible. There is very limited experience using pMRI in ECMO and even less in pediatric ECMO patients, therefore additional feasibility and safety data is needed in this cohort. Methods This single center, IRB approved study was conducted at a free-standing quaternary children’s hospital. All neonatal and pediatric patients cannulated onto ECMO were screened for eligibility. Subjects underwent bedside ultralow-field pMRI with Swoop (Hyperfine, Guilford, CT). Data on ECMO variables, time for patient positioning and scan, MRI sequences, concurrent critical care equipment, changes in ECMO flow and vital signs, and cannula displacement was collected. Results Over a 1-year period (Aug 2023-Aug 2024) 41 patients were screened. 16 out of 20 enrolled subjects had pMRI attempted and 13 (81.25%) received the full imaging protocol (T1, T2, FLAIR and DWI). The median staff members for pMRI positioning was 6 [5, 7] compared to 7 [7,7] for head CT (0.03). The median positioning and pMRI imaging time was 66 min [56, 70] compared to 75 min [70,79] for intrahospital transport for head CT. One subject had a ≥ 20% decrease in mean arterial pressure, however remained within the clinical goals without intervention. Unlike during head CT imaging acquisition, continuous renal replacement therapy was not interrupted during pMRI. Conclusions pMRI is safe and feasible in pediatric ECMO with no clinically relevant complications seen in our cohort. Resource utilization and delivery of concurrent critical care is superior for bedside imaging compared to intrahospital transport to CT. Clinical Trial Registration NCT06074406 https://clinicaltrials.gov/study/NCT06074406?term=NCT06074406Crank=1 What is new? This study expands the experience of ultralow-field portable MRI to pediatric ECMO patients. Ultralow-field portable MRI is feasible and less resource-intense to perform on pediatric ECMO patients compared to intrahospital transport for head CT. Pediatric ECMO patients tolerate bedside MRI without clinically significant changes in ECMO flows, perfusion, or oxygenation. What are the clinical implications? Ultralow-field portable MRI can expand time-sensitive head imaging options for pediatric patients on ECMO with less interruptions of critical care therapies, decreased resource utilization, and eliminated risks of travel and radiation exposure. Timely diagnosis of acute brain injury while on ECMO can prompt changes in neuromonitoring, anticoagulation management, and delivery of neuroprotective care with the intent to improve neurologic outcomes of pediatric ECMO survivors.